Healthcare Value Capital as of Dec. 31, 2011
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 37 positions in its portfolio as reported in the December 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 7.8 | $7.6M | 186k | 40.93 | |
| Medicines Company | 7.3 | $7.1M | 383k | 18.64 | |
| Merck & Co (MRK) | 7.0 | $6.8M | 181k | 37.70 | |
| Sanofi-Aventis SA (SNY) | 5.9 | $5.8M | 158k | 36.54 | |
| Pfizer (PFE) | 5.0 | $4.9M | 226k | 21.64 | |
| St. Jude Medical | 5.0 | $4.8M | 141k | 34.30 | |
| Omnicare | 4.7 | $4.6M | 133k | 34.45 | |
| Medicis Pharmaceutical Corporation | 3.9 | $3.8M | 115k | 33.26 | |
| Express Scripts | 3.7 | $3.6M | 80k | 44.69 | |
| Impax Laboratories | 3.6 | $3.5M | 174k | 20.17 | |
| SPDR S&P MidCap 400 ETF (MDY) | 3.3 | $3.2M | 20k | 159.50 | |
| Pacira Pharmaceuticals (PCRX) | 3.3 | $3.2M | 366k | 8.65 | |
| Qlt | 3.0 | $2.9M | 400k | 7.20 | |
| CVS Caremark Corporation (CVS) | 2.5 | $2.4M | 59k | 40.78 | |
| NuVasive | 2.2 | $2.1M | 170k | 12.59 | |
| Charles River Laboratories (CRL) | 2.2 | $2.1M | 78k | 27.33 | |
| Covidien | 2.2 | $2.1M | 47k | 45.01 | |
| Shire | 2.1 | $2.1M | 20k | 103.90 | |
| Wright Medical | 2.1 | $2.1M | 125k | 16.50 | |
| ProShares UltraShort Euro (EUO) | 2.1 | $2.0M | 100k | 20.35 | |
| Tenet Healthcare Corporation | 2.1 | $2.0M | 390k | 5.13 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.0 | $1.9M | 58k | 33.22 | |
| Chemed Corp Com Stk (CHE) | 1.9 | $1.8M | 36k | 51.21 | |
| CryoLife (AORT) | 1.9 | $1.8M | 375k | 4.80 | |
| Elan Corporation | 1.8 | $1.8M | 130k | 13.74 | |
| C.R. Bard | 1.8 | $1.7M | 20k | 85.50 | |
| Eli Lilly & Co. (LLY) | 1.5 | $1.5M | 35k | 41.57 | |
| Bristol Myers Squibb (BMY) | 1.4 | $1.4M | 40k | 35.25 | |
| Mead Johnson Nutrition | 1.4 | $1.4M | 20k | 68.75 | |
| Community Health Systems (CYH) | 1.3 | $1.2M | 70k | 17.46 | |
| Obagi Medical Products | 1.2 | $1.2M | 113k | 10.16 | |
| Clovis Oncology | 0.7 | $705k | 50k | 14.10 | |
| Boston Scientific Corporation (BSX) | 0.6 | $539k | 101k | 5.34 | |
| Mylan | 0.6 | $537k | 25k | 21.48 | |
| Celsion Corporation | 0.4 | $425k | 251k | 1.69 | |
| PROLOR Biotech | 0.2 | $240k | 56k | 4.28 | |
| Skilled Healthcare | 0.2 | $218k | 40k | 5.45 |
